| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Commercial | SVP Commercial
1 company
McCourt Marion is an EVP Commercial at REGN. Recent filings cover 0 purchases and 52 sales. Those positions are worth an estimated $10.3M at current prices.
Our model assigns McCourt Marion a middling insider score of 55/100, based on 47 past trades. Over a 12-month horizon, 31.9% of those trades were profitable, with an average 12-month return of -4.9%.
McCourt Marion's largest disclosed position is in REGN as EVP Commercial, worth about $10.3M. The recent filings there lean toward selling, a net 44,279 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sell10b5-1 | 2,346 | $853.56 | $2,002,458.09 | -16.3% | - | - | |
| Nov 1, 2024 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE10b5-1 | 1,000 | $844.61 | $844,610.00 | -7.2% | -19.0% | -22.7% | |
| Oct 1, 2024 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE10b5-1 | 1,000 | $1,054.06 | $1,054,060.00 | -7.2% | -32.9% | -42.7% | |
| Sep 3, 2024 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE10b5-1 | 1,000 | $1,178.73 | $1,178,730.00 | -7.2% | -34.8% | -51.8% | |
| Aug 1, 2024 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE10b5-1 | 1,137 | $1,060.86 | $1,206,197.82 | -8.1% | -15.6% | -48.9% | |
| Jul 1, 2024 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE10b5-1 | 1,137 | $1,047.11 | $1,190,564.07 | -8.1% | -0.5% | -49.4% | |
| Jun 3, 2024 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE10b5-1 | 1,138 | $980.16 | $1,115,422.08 | -8.1% | +18.1% | -50.7% | |
| May 1, 2024 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sell10b5-1 | 250 | $889.41 | $222,352.50 | -1.9% | +19.3% | -34.7% | |
| Apr 1, 2024 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sell10b5-1 | 250 | $964.73 | $241,182.50 | -1.9% | +9.0% | -36.3% | |
| Mar 1, 2024 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sell10b5-1 | 358 | $967.50 | $346,365.00 | -2.6% | -1.3% | -28.9% |